Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2018

06.08.2018 | Original Article

Effect of Helicobacter pylori Infection on GATA-5 and TFF1 Regulation, Comparison Between Pediatric and Adult Patients

verfasst von: Marisa Claudia Alvarez, Julien Fernandes, Valérie Michel, Eliette Touati, Marcelo Lima Ribeiro

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

GATA factors, which constitute a family of transcription regulatory proteins, participate in gastrointestinal development. Trefoil factor 1 (TFF1) plays a crucial role in mucosal defense and healing, and evidence suggests that GATA-5 mediated its regulation. Gastric cancer is a multiple-step process triggered by Helicobacter pylori and is characterized by accumulation of molecular and epigenetic alteration. The aim of this study was to evaluate the effect of H. pylori infection on the regulation of GATA-5 and TFF1 in vitro and in vivo.

Results

Infected cells exhibited upregulation of GATA-5 and TFF1 after 48 h. An increase in GATA-5 and TFF1 mRNA levels was also found in mice samples after 6 and 12 months of infection, respectively. In human samples, we found an association between H. pylori infection and GATA-5 upregulation. In fact, among H. pylori-infected patients, hypermethylation was observed in 45.5% of pediatric samples, in 62.6% of chronic gastritis samples, and in 63% of gastric cancer samples. Regarding TFF1, the expression levels were similar in pediatrics and adults patients, and were independent of H. pylori infection, and the expression of these factors was downregulated in gastric cancer samples. GATA-5 promoter methylation was associated with a decrease in TFF1 mRNA levels.

Conclusions

Our results suggest that the upregulation of GATA-5 and TFF1 observed in vitro and in vivo may be correlated with a protective effect of the mucosa in response to infection. The epigenetic inactivation of GATA-5 observed in human biopsies from infected patients may suggest that this alteration is an early event occurring in association with H. pylori infection.
Literatur
1.
Zurück zum Zitat Drumm B. Helicobacter pylori in the pediatric patient. Gastroenterol Clin N Am. 1993;22:169–182. Drumm B. Helicobacter pylori in the pediatric patient. Gastroenterol Clin N Am. 1993;22:169–182.
2.
Zurück zum Zitat Drumm B, Day AS, Gold B, et al. Helicobacter pylori and peptic ulcer. Working group report of the second world congress of pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2004;39:S626–S631.CrossRef Drumm B, Day AS, Gold B, et al. Helicobacter pylori and peptic ulcer. Working group report of the second world congress of pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2004;39:S626–S631.CrossRef
3.
Zurück zum Zitat Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res. 2011;1:9–17.CrossRef Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res. 2011;1:9–17.CrossRef
4.
Zurück zum Zitat Ding SZ, Goldberg JB, Hatekeyama M. Helicobacter pylori infection, oncogenic pathways and epigenetics mechanism in gastric carcinogenesis. Future Oncol. 2010;6:851–862.CrossRef Ding SZ, Goldberg JB, Hatekeyama M. Helicobacter pylori infection, oncogenic pathways and epigenetics mechanism in gastric carcinogenesis. Future Oncol. 2010;6:851–862.CrossRef
5.
Zurück zum Zitat Roa JCS, García P, Melo A, et al. Gene methylation patterns in digestive tumors. Rev Méd Chile. 2008;136:451–458. Roa JCS, García P, Melo A, et al. Gene methylation patterns in digestive tumors. Rev Méd Chile. 2008;136:451–458.
6.
Zurück zum Zitat Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427–5440.CrossRef Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427–5440.CrossRef
7.
Zurück zum Zitat Esteller M. CpG island methylation and histone modifications: biology and significance. ErnstSchering Res Found Workshop. 2006;57:115–126.CrossRef Esteller M. CpG island methylation and histone modifications: biology and significance. ErnstSchering Res Found Workshop. 2006;57:115–126.CrossRef
8.
Zurück zum Zitat Kang GH, Shim YH, Jung HY, et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001;61:2847–2851.PubMed Kang GH, Shim YH, Jung HY, et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001;61:2847–2851.PubMed
9.
Zurück zum Zitat Waki T, Tamura G, Tsuchiya T, et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol. 2002;161:399–403.CrossRef Waki T, Tamura G, Tsuchiya T, et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol. 2002;161:399–403.CrossRef
10.
Zurück zum Zitat Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 2003;52:502–506.CrossRef Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 2003;52:502–506.CrossRef
11.
Zurück zum Zitat Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006;12:989–995.CrossRef Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006;12:989–995.CrossRef
12.
Zurück zum Zitat Nakajima T, Yamashita S, Maekita T, et al. The presence of a methylation fingerprint of Helicobacter infection in human gastric mucosae. Int J Cancer. 2009;124:905–910.CrossRef Nakajima T, Yamashita S, Maekita T, et al. The presence of a methylation fingerprint of Helicobacter infection in human gastric mucosae. Int J Cancer. 2009;124:905–910.CrossRef
13.
Zurück zum Zitat Bussière F, Michel V, Mémet S, et al. H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression. Cell Microbiol. 2010;12:1124–1133.CrossRef Bussière F, Michel V, Mémet S, et al. H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression. Cell Microbiol. 2010;12:1124–1133.CrossRef
14.
Zurück zum Zitat Alvarez MC, Santos JC, Maniezzo N, et al. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. World J Gastroenterol. 2013;19:3043–3051.CrossRef Alvarez MC, Santos JC, Maniezzo N, et al. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. World J Gastroenterol. 2013;19:3043–3051.CrossRef
16.
Zurück zum Zitat Zheng R, Blobel GA. GATA transcription factors and cancer. Genes Cancer. 2010;12:1178–1188.CrossRef Zheng R, Blobel GA. GATA transcription factors and cancer. Genes Cancer. 2010;12:1178–1188.CrossRef
17.
Zurück zum Zitat Laverriere A, MacNeill C, Mueller C, et al. GATA-4/5/6, a subfamily of three transcription factors transcribed in the developing heart and gut. J Biol Chem. 1994;269:23177–23184. Laverriere A, MacNeill C, Mueller C, et al. GATA-4/5/6, a subfamily of three transcription factors transcribed in the developing heart and gut. J Biol Chem. 1994;269:23177–23184.
18.
Zurück zum Zitat Wen X, Akiyama Y, Pan KF, et al. Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J Gastroenterol. 2010;16:1201–1208.CrossRef Wen X, Akiyama Y, Pan KF, et al. Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J Gastroenterol. 2010;16:1201–1208.CrossRef
19.
Zurück zum Zitat Akiyama Y, Watkins N, Suzuki H, et al. GATA-4 and GATA-5 transcription factor genes and potential dowstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol. 2003;23:8429–8439.CrossRef Akiyama Y, Watkins N, Suzuki H, et al. GATA-4 and GATA-5 transcription factor genes and potential dowstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol. 2003;23:8429–8439.CrossRef
20.
Zurück zum Zitat Guo M, Akiyama Y, House MG, et al. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res. 2004;10:7917–7924.CrossRef Guo M, Akiyama Y, House MG, et al. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res. 2004;10:7917–7924.CrossRef
21.
Zurück zum Zitat Guo M, House MG, Akiyama Y, et al. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006;119:2078–2083.CrossRef Guo M, House MG, Akiyama Y, et al. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006;119:2078–2083.CrossRef
22.
Zurück zum Zitat Wu MS, Shun CT, Wang HP, et al. Loss of pS2 protein expression is an early event of intestinal-type gastric cancer. J Cancer Res. 1998;89:278–282. Wu MS, Shun CT, Wang HP, et al. Loss of pS2 protein expression is an early event of intestinal-type gastric cancer. J Cancer Res. 1998;89:278–282.
23.
Zurück zum Zitat Touati E, Michel V, Thiberge JM, et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003;124:1408–1419.CrossRef Touati E, Michel V, Thiberge JM, et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003;124:1408–1419.CrossRef
24.
Zurück zum Zitat Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−∆∆(CT)) method. Methods. 2001;25:402–408.CrossRef Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−∆∆(CT)) method. Methods. 2001;25:402–408.CrossRef
25.
Zurück zum Zitat Jones PA, Baylin SB. The fundamental role of epigenetics events in cancer. Nat Rev Genet. 2002;3:415–428.CrossRef Jones PA, Baylin SB. The fundamental role of epigenetics events in cancer. Nat Rev Genet. 2002;3:415–428.CrossRef
26.
Zurück zum Zitat Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 1996;274:259–262.CrossRef Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 1996;274:259–262.CrossRef
27.
Zurück zum Zitat Mashimo H, Wu DC, Podolsky DK, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274:262–265.CrossRef Mashimo H, Wu DC, Podolsky DK, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274:262–265.CrossRef
28.
Zurück zum Zitat Lassus H, Laitinen MP, Anttonen M, et al. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab Invest. 2001;81:517–526.CrossRef Lassus H, Laitinen MP, Anttonen M, et al. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab Invest. 2001;81:517–526.CrossRef
29.
Zurück zum Zitat Rio MC, Chenard MP, Wolf C, et al. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology. 1991;100:375–379.CrossRef Rio MC, Chenard MP, Wolf C, et al. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology. 1991;100:375–379.CrossRef
30.
Zurück zum Zitat Baylin S, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6:107–116.CrossRef Baylin S, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6:107–116.CrossRef
31.
Zurück zum Zitat Nardone G, Compare D. Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:243–248.CrossRef Nardone G, Compare D. Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:243–248.CrossRef
32.
Zurück zum Zitat Nan HM, Song YJ, Yun HY, et al. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol. 2005;25:3834–3841.CrossRef Nan HM, Song YJ, Yun HY, et al. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol. 2005;25:3834–3841.CrossRef
33.
Zurück zum Zitat Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;8:599–612.CrossRef Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;8:599–612.CrossRef
34.
Zurück zum Zitat Tahara T, Hibata T, Nakamura M, et al. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa. Int J Mol Med. 2009;24:563–569.CrossRef Tahara T, Hibata T, Nakamura M, et al. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa. Int J Mol Med. 2009;24:563–569.CrossRef
35.
Zurück zum Zitat Gao X, Sedgwick T, Shi YB, et al. Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol Cell Biol. 1998;18:2901–2911.CrossRef Gao X, Sedgwick T, Shi YB, et al. Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol Cell Biol. 1998;18:2901–2911.CrossRef
36.
Zurück zum Zitat Soutto M, Belkhiri A, Piazuelo MB, et al. Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest. 2011;121:1753–1767.CrossRef Soutto M, Belkhiri A, Piazuelo MB, et al. Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest. 2011;121:1753–1767.CrossRef
37.
Zurück zum Zitat Soutto M, Chen Z, Katsha AM, et al. Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis. Cancer. 2015;121:4348–4358.CrossRef Soutto M, Chen Z, Katsha AM, et al. Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis. Cancer. 2015;121:4348–4358.CrossRef
38.
Zurück zum Zitat Sobota RS, Kodaman N, Mera R, et al. Epigenetic and genetic variation in GATA5 is associated with gastric disease risk. Hum Genet. 2016;135:895–906.CrossRef Sobota RS, Kodaman N, Mera R, et al. Epigenetic and genetic variation in GATA5 is associated with gastric disease risk. Hum Genet. 2016;135:895–906.CrossRef
39.
Zurück zum Zitat McClain M, Shaffer CL, Israel DA, et al. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genom. 2009;10:3.CrossRef McClain M, Shaffer CL, Israel DA, et al. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genom. 2009;10:3.CrossRef
40.
Zurück zum Zitat Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5:1166–1174.CrossRef Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5:1166–1174.CrossRef
41.
Zurück zum Zitat Lee A, Rourke J, De Ungria MC, Robertson B, et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997;112:1386–1397.CrossRef Lee A, Rourke J, De Ungria MC, Robertson B, et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997;112:1386–1397.CrossRef
42.
Zurück zum Zitat Vivas JR, Regnault B, Michel V, et al. Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection. Int J Immunopathol Pharmacol. 2008;21:515–526.CrossRef Vivas JR, Regnault B, Michel V, et al. Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection. Int J Immunopathol Pharmacol. 2008;21:515–526.CrossRef
43.
Zurück zum Zitat Dixon M, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.CrossRef Dixon M, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.CrossRef
44.
Zurück zum Zitat Coelho LGV, Barros CA, Lima DCA. National consensus on ‘‘H. pylori’’. GED. 1996;15:53–58. Coelho LGV, Barros CA, Lima DCA. National consensus on ‘‘H. pylori’’. GED. 1996;15:53–58.
45.
Zurück zum Zitat Mikula M, Dzwonek A, Jagusztyn-Krynicka K, et al. Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J Microbiol Methods. 2003;55:351–359.CrossRef Mikula M, Dzwonek A, Jagusztyn-Krynicka K, et al. Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J Microbiol Methods. 2003;55:351–359.CrossRef
Metadaten
Titel
Effect of Helicobacter pylori Infection on GATA-5 and TFF1 Regulation, Comparison Between Pediatric and Adult Patients
verfasst von
Marisa Claudia Alvarez
Julien Fernandes
Valérie Michel
Eliette Touati
Marcelo Lima Ribeiro
Publikationsdatum
06.08.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5223-0

Weitere Artikel der Ausgabe 11/2018

Digestive Diseases and Sciences 11/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.